End-of-day quote
Nasdaq
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
1.66
USD
|
-0.60%
|
|
-0.60%
|
+62.75%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
43.11
|
52.05
|
89.61
|
-
|
-
|
Enterprise Value (EV)
1 |
43.11
|
52.05
|
89.61
|
89.61
|
89.61
|
P/E ratio
|
-
|
-2.04
x
|
-3.26
x
|
-2.91
x
|
-2.67
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-2,066,643
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-2,254,127
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
50,736
|
51,025
|
54,978
|
-
|
-
|
Reference price
2 |
0.8497
|
1.020
|
1.630
|
1.630
|
1.630
|
Announcement Date
|
3/31/23
|
3/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-20.86
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-21.24
|
-26.96
|
-27.09
|
-31.56
|
-36.87
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-25.65
|
-27.09
|
-31.56
|
-36.87
|
Net income
1 |
-12.77
|
-
|
-25.65
|
-27.09
|
-31.56
|
-36.87
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-1.170
|
-
|
-0.5000
|
-0.5000
|
-0.5600
|
-0.6100
|
Free Cash Flow
|
-
|
-19.12
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/24/22
|
3/31/23
|
3/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-7.003
|
-7.144
|
-6.217
|
-6.227
|
-6.468
|
-6.989
|
-7.291
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-6.526
|
-6.782
|
-6.026
|
-6.039
|
-6.468
|
-6.989
|
-7.291
|
Net income
1 |
-6.318
|
-6.526
|
-6.782
|
-6.026
|
-6.039
|
-6.468
|
-6.989
|
-7.291
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.1200
|
-0.1300
|
-0.1300
|
-0.1200
|
-0.1200
|
-0.1200
|
-0.1300
|
-0.1300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/15/23
|
8/14/23
|
11/13/23
|
3/26/24
|
5/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-19.1
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/24/22
|
3/31/23
|
3/26/24
|
-
|
-
|
-
|
Last Close Price
1.63
USD Average target price
8
USD Spread / Average Target +390.80% Consensus |
1st Jan change
|
Capi.
|
---|
| +62.75% | 90.16M | | +13.73% | 130B | | -8.17% | 10.97B | | -4.33% | 8.42B | | +41.80% | 5.57B | | -21.94% | 4.59B | | +7.81% | 3.42B | | -10.26% | 2.73B | | -10.29% | 2.08B | | -13.58% | 1.92B |
Medical Devices & Implants
|